Here are the top health stories for the day:

NMC Updates 2026-27 MBBS Seat Matrix: 1,40,664 Seats Across 839 Colleges

Altogether 1,40,664 MBBS seats are available in India for the academic year 2026-2027, according to the updated seat matrix released by the National Medical Commission (NMC) recently.

The latest seat matrix shows that 1,27,028 MBBS seats have been renewed, while 13,636 seats have been increased across 839 medical colleges in the country.

For more details, check out the full story on the link mentioned below:


Doctors' Body Urges Rajasthan DME to Release Internship Stipend, Pending Arrears to FMG Interns
Coming in support of the protesting Foreign Medical Graduates (FMG) interns in Rajasthan, a doctors' body has urged the Directorate of Medical Education (DME) to release the stipend dues along with pending arrears to eligible FMG interns undergoing Compulsory Rotating Medical Internship (CRMI) across the state.

The ongoing protest by the interns entered its seventh day today, with the medicos urging the concerned authorities to release their pending stipend in compliance with the directions issued by the Supreme Court.

For more details, check out the full story on the link mentioned below:

Release internship stipend, pending arrears to FMG interns: Doctors' body urges Rajasthan DME

NEET MBBS Quota: 2 Arrested Over Alleged Fake Freedom Fighter Certificates in Uttarakhand

The Special Investigation Team (SIT) of Uttarakhand Police has arrested two people in connection with the alleged submission of fake freedom fighter and domicile certificates during the NEET-UG 2025 admission process to secure MBBS seats.

Meanwhile, the Uttarakhand Medical Education Department has directed principals of all 10 government and private medical colleges participating in the counselling to verify the documents.

For more details, check out the full story on the link mentioned below:

Uttarakhand MBBS seat fraud: SIT arrests 2 over alleged fake certificates, govt orders medical colleges to verify documents

Health Ministry Warns Against Painkiller, Antibiotic Misuse, Cites Kidney Disease Risk

The Central Drugs Standard Control Organisation (CDSCO) has issued an advisory warning healthcare professionals, pharmacists, retailers, distributors, hospitals and the public against the indiscriminate use of painkillers, particularly Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), and antibiotics due to the risk of kidney damage and Chronic Kidney Disease (CKD). The advisory, dated September 21, stressed that these medicines should be used only when clinically indicated, at the appropriate dose and for the appropriate duration, under the supervision of a Registered Medical Practitioner. Most NSAIDs are listed under Schedule H of the Drugs Rules, 1945 and cannot be sold at retail without a prescription. Most antibiotics are listed under Schedule H1 and carry specific warnings regarding prescription-only use.

The advisory urged the public not to repeatedly or unnecessarily use NSAIDs or antibiotics without medical advice. Antibiotics should not be self-medicated, used for uncomplicated viral infections, shared with others or taken from leftover medicines. People with existing kidney disease or other risk factors for renal impairment were advised to inform their healthcare providers before taking NSAIDs. Doctors were asked to consider age, co-morbidities, other medicines and kidney-related risk factors, while using the lowest effective NSAID dose for the shortest appropriate duration. Healthcare institutions and pharmacies were also directed to strengthen prescription monitoring, antimicrobial stewardship and compliance with rules governing prescription medicines, reports ANI.

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .